Intracellular bacteria in the pathogenesis of escherichia coli urinary tract infection in children

Clinical Infectious Diseases

Volumn 59, Issue 11, 2014, Pages e158-e164

  Robino, Luciana ^a   Scavone, Paola ^b   Araujo, Lucia ^a   Algorta, Gabriela ^a,c   Zunino, Pablo ^b   Pírez, María Catalina ^a   Vignoli, Rafael ^a  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^b INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

^c Centro Hospitalario Pereira Rossell   (Uruguay)

Author keywords

E. coli pathogenicity; Intracellular bacterial communities; Urinary tract infection

Indexed keywords

VIRULENCE FACTOR;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BACTERIAL VIRULENCE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONFOCAL MICROSCOPY; DIARRHEA; FEMALE; FEVER; HUMAN; INFANT; INTRACELLULAR SPACE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; RECURRENT DISEASE; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; VOMITING; WEIGHT GAIN; CYTOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETICS; MICROBIOLOGY; PATHOGENICITY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; UROTHELIUM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT; INTRACELLULAR SPACE; MALE; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS; UROTHELIUM;

EID: 84920877678     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu634     Document Type: Article

References (35)

1. Elder S. Infecciones del tracto urinario. In: Kliegman R, Behrman R, Jenson H, Stanton B, eds. In: Nelson tratado de pediatría. 18th ed. Madrid: Elsevier, 2009: 2223-8.
2. Habib S. Highlights for management of a child with a urinary tract infection. Int J Pediatr 2012; 2012: 943653.
3. Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003; 17: 227-41.
4. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
5. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-72.
6. Nielubowicz GR, Mobley HL. Host-pathogen interactions in urinary tract infection. Nat Rev Urol 2010; 7: 430-41.
7. Johnson JR, Kuskowski MA, Owens K, Gajewski A, Winokur PL. Phylogenetic origin and virulence genotyping relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis 2003; 188: 759-68.
8. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Douglas R, Bennett JE. Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier, 2005: 875-905.
9. Mysorekar IU, Hultgren SJ. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 2006; 103: 14170-5.
10. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser R, Hultgren S. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003; 301: 105-7.
11. Garofalo C, Hooton T, Martin S, et al. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun 2007; 75: 52-60.
12. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 2007; 4: 1949-57.
13. Robino L, Scavone P, Araujo L, Algorta G, Zunino P, Vignoli R. Detection of intracellular bacterial communities in a child with Escherichia coli urinary tract infection. Pathog Dis 2013; 68: 78-81.
14. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001; 69: 4572-9.
15. Justice SS, Hung C, Theriot JA, et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 2004; 101: 1333-8.
16. Anderson GG, Dodson K, Hooton T, Hultgren S. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol 2004; 12: 424-30.
17. Blango MG, Mulvey MA. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 2010; 54: 1855-63.
18. Justice SS, Hunstad DA, Seed PC, Hultgren SJ. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A 2006; 103: 19884-9.
19. Andersen TE, Khandige S, Madelung M, Brewer J, Kolmos HJ, Møller-Jensen J. Escherichia coli uropathogenesis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection model. Infect Immun 2012; 80: 1858-67.
20. Schwartz DJ, Chen SL, Hultgren SJ, Seed PC. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Infect Immun 2011; 79: 4250-9.
21. Hsieh MH, Madden-Fuentes RJ, Roth DR. Urologic diagnoses among infants hospitalized for urinary tract infection. Urology 2009; 74: 100-3.
22. Caggiani M, Barreiro A, Schol P. Infección urinaria en niños internados: características clínicas, bacteriológicas e imagenológicas. Arch Pediatr Urug 2002; 73: 203-11.
23. Ragnarsdóttir B, Svanborg C. Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol 2012; 27: 2017-29.
24. Sivick KE, Mobley HLT Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 2010; 78: 568-85.
25. Garin E, Olavarria F, Garcia V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006; 117: 626-32.
26. Conway P, Cnaan A, Zaoutis T, Henry BV, Grundmeier RW, Keren R. Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007; 298: 179-86.
27. Nuutinen M, Uhari M. Recurrence and follow-up after urinary tract infection under the age of 1 year. Pediatr Nephrol 2001; 16: 69-72.
28. Schlapp G, Scavone P, Zunino P, Hartel S. Development of 3D architecture of uropathogenic Proteus mirabilis batch culture biofilms - a quantitative confocal microscopy approach. J Microbiol Methods 2011; 87: 234-40.
29. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-72.
30. Schilling JD, Lorenz RG, Hultgren SJ. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 2002; 70: 7042-9.
31. Horvath DJ Jr, Li B, Casper T, et al. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect 2011; 13: 426-37.
32. Giachetto G, Pérez W, Prego J, Saráchaga MJ. Infección urinaria. In: Atención pediátrica. Normas nacionales de diagnóstico, tratamiento y prevención. 7th ed. Montevideo: Oficina del Libro FEFMUR, 2008; 221-8.
33. Mechelow IC, McCracken GH. Antibacterial therapeutic agents. In: Feijin R, Cherry J, Demmler-Harrison G, Kaplan S. Textbook of pediatric infectious diseases. 6th ed. Philadelphia: Elsevier, 2009: 3178-227.
34. Blango MG, Ott EM, Erman A, Veranic P, Mulvey MA. Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLoS One 2014; 9: e93327.
35. Mysorekar IU, Hultgren SJ. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 2006; 103: 14170-5.